Starling Oncology (STLN) vs U.S. Physical Therapy (USPH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Starling Oncology (STLN) has outperformed U.S. Physical Therapy (USPH) over the past year, gaining 68.3% versus a loss of 7.6%. Over five years, USPH leads with a -20.6% price change compared with -35.4% for STLN. U.S. Physical Therapy is the larger company by market cap ($1.24 billion vs $655.3 million), about 1.9 times the size.
U.S. Physical Therapy pays a dividend yielding 2.19%, while Starling Oncology does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | STLN | USPH |
|---|---|---|
| Share price | $6.43 | $82.96 |
| Market cap | $655.32M | $1.24B |
| 1-day change | -2.28% | -0.80% |
| YTD return | +80.62% | +6.24% |
| 1-year return | +68.32% | -7.59% |
| 5-year return | -35.38% | -20.64% |
| P/E ratio (TTM) | — | 460.89 |
| Forward P/E | — | 24.76 |
| EPS (TTM) | $-0.29 | $0.18 |
| Dividend yield | 0.00% | 2.19% |
| Annual dividend | $0.00 | $1.82 |
| 52-week high | $7.13 | $93.50 |
| 52-week low | $2.32 | $58.19 |
| Distance from 52-week high | -9.82% | -11.27% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +39.97% | +16.92% |
| Average volume | 1.55M | 204.60K |
| Shares outstanding | 101.92M | 14.92M |
| Employees | 641 | 4,653 |
| Sector | Health Care | Health Care |
| Industry | Medical/Nursing Services | Medical/Nursing Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- STLN has outperformed USPH by 75.9 percentage points over the past year.
- U.S. Physical Therapy offers a meaningfully higher dividend yield (2.19% vs 0.00%).
About Starling Oncology
STLN stock →Starling Oncology, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other.
Health Care · Medical/Nursing Services · 641 employees
About U.S. Physical Therapy
USPH stock →U.S. Physical Therapy, Inc., together with its subsidiaries, operates and manages outpatient physical therapy clinics.
Health Care · Medical/Nursing Services · 4,653 employees
STLN vs USPH FAQ
Which is bigger, Starling Oncology or U.S. Physical Therapy?
U.S. Physical Therapy (USPH) is larger, with a market capitalization of $1.24B compared with $655.32M for Starling Oncology (STLN).
Which stock has performed better over the past year, STLN or USPH?
STLN returned +68.32% over the past 12 months, compared with -7.59% for USPH (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Starling Oncology or U.S. Physical Therapy?
U.S. Physical Therapy pays a dividend yielding 2.19%, while Starling Oncology does not currently pay a regular dividend.
Are Starling Oncology and U.S. Physical Therapy in the same industry?
Yes. Both are classified in the Medical/Nursing Services industry within the Health Care sector.